Chemokine Receptor Type 4 Interaction [EPC] - N0000193866
Pharmacologic Class Information
| Pharmacologic Code | N0000193866 |
| Pharmacologic Name | Chemokine Receptor Type 4 Interaction |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
| Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Chemokine Receptor Type 4 Interaction
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Chemokine Receptor Type 4 Interaction [EPC].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 42747-761 | Poteligeo | Non-Proprietary Name: Mogamulizumab-kpkc | Injection | Intravenous | Kyowa Kirin, Inc. | ACTIVE |